Eli Lilly to buy Ventyx Biosciences in $1.2 billion deal

Ventyx Biosciences

07/01/2026 21:22

Jan 7 (Reuters) - Eli Lilly LLY.N will buy Ventyx Biosciences VTYX.O in an all-cash deal worth $1.2 billion, the companies said on Wednesday, marking the Zepbound maker's latest push to expand beyond its blockbuster diabetes and weight-loss drugs.

 (Reporting by Mrinalika Roy and Puyaan Singh in Bengaluru; Editing by Leroy Leo and Tasim Zahid)

 ((mrinalika.roy@thomsonreuters.com;))